Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a biopharmaceutical company developing innovative therapeutics to fight breast cancer, one of the most common and devastating diseases impacting women. Led by renowned physician-scientist Dr. Steven Quay, the Company has a powerful mission: to change the trajectory and outcomes of breast cancer.

It is in active regulatory dialogue with the FDA to accelerate the development of its lead product candidate, (Z)-endoxifen, to reduce breast cancer incidence in high-risk women and in select treatment settings.